Tetrapeptides, as small-sized peptidic inhibitors; synthesis and their inhibitory activity against BACE1

Journal of Peptide Science

Volumn 16, Issue 6, 2010, Pages 257-262

  Kakizawa, Taeko ^a   Hidaka, Koushi ^a   Hamada, Daisuke ^a   Yamaguchi, Ryoji ^a   Uemura, Tsuyoshi ^a   Kitamura, Hitomi ^a   Tagad, Harichandra D ^a   Hamada, Takashi ^a   Ziora, Zyta ^a   Hamada, Yoshio ^a   Kimura, Tooru ^a   Kiso, Yoshiaki ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; BACE1 inhibitors; Liquid phase peptide synthesis; Tetrapeptides

Indexed keywords

BETA SECRETASE 1; PEPTIDOMIMETIC AGENT; TETRAPEPTIDE;

ALZHEIMER DISEASE; ARTICLE; DRUG ACTIVITY; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; HUMAN; IC 50; PEPTIDE SYNTHESIS; PRIORITY JOURNAL;

AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ACID ENDOPEPTIDASES; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; INHIBITORY CONCENTRATION 50; MOLECULAR STRUCTURE; OLIGOPEPTIDES;

EID: 77953458276     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1238     Document Type: Article

References (27)

1. Selkoe DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999; 399: A23-A31. (Pubitemid 129519185)
2. Sinha S, Lieberburg I. Cellular mechanisms of β-amyloid production and secretion. Proc. Natl. Acad. Sci., U. S. A. 1999; 96: 11049-11053.
3. Stachel SJ. Progress toward the development of a viable BACE-1 inhibitor. Drug Dev. Res. 2009; 70: 101-110.
4. Hills ID, Vacca JP. Progress toward a practical BACE-1 inhibitor. Curr. Opin. Drug Discov. Dev. 2007; 10: 383-391.
5. Ziora Z, Kimura T, Kiso Y. Small-sized BACE1 inhibitors. Drugs Fut. 2006; 31: 53-63.
6. Shuto D, Kasai S, Kimura T, Liu P, Hidaka K, Hamada T, Shibakawa S, Hayashi Y, Hattori C, Szabo B, Ishiura S, Kiso Y. KMI-008, a novel β-secretase inhibitor containing a hydroxymethylcarbonyl isostere as a transition-state mimic: design and synthesis of substrate-based octapeptides. Bioorg. Med. Chem. Lett. 2003; 13: 4273-4276.
7. Kimura T, Shuto D, Kasai S, Liu P, Hidaka K, Hamada T, Hayashi Y, Hattori C, Asai M, Kitazume S, Saido TC, Ishiura S, Kiso Y. KMI-358 and KMI-370, highly potent and small-sized BACE1 inhibitors containing phenylnorstatine. Bioorg. Med. Chem. Lett. 2004; 14: 1527-1531. (Pubitemid 38299443)
8. Kimura T, Shuto D, Hamada Y, Igawa N, Kasai S, Liu P, Hidaka K, Hamada T, Hayashi Y, Kiso Y. Design and synthesis of highly active Alzheimer's β-secretase (BACE1) inhibitors, KMI-420 and KMI-429, with enhanced chemical stability. Bioorg. Med. Chem. Lett. 2005; 15: 211-215.
9. Kimura T, Hamada Y, Stochaj M, Ikari H, Nagamine A, Abdel-Rahman H, Igawa N, Hidaka K, Nguyen J-T, Saito K, Hayashi Y, Kiso Y. Design and synthesis of potent β-secretase (BACE1) inhibitors with P1′ carboxylic acid bioisosteres. Bioorg. Med. Chem. Lett. 2006; 16: 2380-2386.
10. Hamada Y, Igawa N, Ikari H, Ziora Z, Nguyen J-T, Yamani A, Hidaka K, Kimura T, Saito K, Hayashi Y, Ebina M, Ishiura S, Kiso Y. β-Secretase inhibitors: modification at the P4 position and improvement of inhibitory activity in cultured cells. Bioorg. Med. Chem. Lett. 2006; 16: 4354-4359.
11. Ziora Z, Kasai S, Hidaka K, Nagamine A, Kimura T, Hayashi Y, Kiso Y. Design and synthesis of BACE1 inhibitors containing a novel norstatine derivative (2R,3R)-3-amino-2-hydroxy-4-(phenylthio) butyric acid. Bioorg. Med. Chem. Lett. 2007; 17: 1629-1633.
12. Hamada Y, Abdel-Rahman H, Yamani A, Nguyen J-T, Stochaj M, Hidaka K, Kimura T, Hayashi Y, Saito K, Ishiura S, Kiso Y. BACE1 inhibitors: optimization by replacing the P1′ residue with non-acidic moiety. Bioorg. Med. Chem. Lett. 2008; 18: 1649-1653. (Pubitemid 351318248)
13. Asai M, Hattori C, Iwata N, Saido TC, Sasagawa N, Szabo B, Hashimoto Y, Maruyama K, Tanuma S, Kiso Y, Ishiura S. The novel β-secretase inhibitor KMI-429 reduces amyloid β peptide production in amyloid precursor protein transgenic and wild-type mice. J. Neurochem. 2006; 96: 533-540.
14. Hamada Y, Kiso Y. Recent progress in the drug discovery of non-peptidic BACE1 inhibitors. Exp. Opin. Drug Discov. 2009; 4: 391-416.
15. Hom RK, Gailunas AF, Mamo S, Fang LY, Tung JS, Walker DE, Davis D, Thorsett ED, Jewett NE, Moon JB, John V. Design and synthesis of hydroxyethylene-based peptidomimetic inhibitors of human β-secretase. J.Med. Chem. 2004; 47: 158-164.
16. Stachel SJ, Coburn CA, Steele TG, Jones KG, Loutzenhiser EF, Gregro AR, Rajapakse HA, Lai M-T, Crouthamel M-C, Xu M, Tugusheva K, Lineberger JE, Pietrak BL, Espeseth AS, Shi X-P, Chen-Dodson E, Holloway MK, Munshi S, Simon AJ, Kuo L, Vacca JP. Structure-based design of potent and selective cell-permeable inhibitors of human β-secretase (BACE-1). J. Med. Chem. 2004; 47: 6447-6450.
17. Hamada Y, Ohta H, Miyamoto N, Yamaguchi R, Yamani A, Hidaka K, Kimura T, Saito K, Hayashi Y, Ishiura S, Kiso Y. Novel non-peptidic and small-sized BACE1 inhibitors. Bioorg. Med. Chem. Lett. 2008; 18: 1654-1658.
18. Barrow JC, Stauffer SR, Rittle KE, Ngo PL, Yang Z, Selnick HG, Graham SL, Munshi S, McGaughey GB, Holloway MK, Simon AJ, Price EA, Sankaranarayanan S, Colussi D, Tugusheva K, Lai MT, Espeseth AS, Xu M, Huang Q, Wolfe A, Pietrak B, Zuck P, Levorse DA, Hazuda D, Vacca JP. Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of β-secretase. J. Med. Chem. 2008; 51: 6259-6262.
19. Ghosh AK, Kumaragurubaran N, Hong L, Kulkarni S, Xu X, Miller HB, Reddy DS, Weerasena V, Turner R, Chang W, Koelsch G, Tang J. Potent memapsin 2 (β-secretase) inhibitors: design, synthesis, protein-ligand X-ray structure, and in vivo evaluation. Bioorg. Med. Chem. Lett. 2008; 18: 1031-1036.
20. Barazza A, Götz M, Cadamuro SA, Goettig P, Willem M, Steuber H, Kohler T, Jestel A, Reinemer P, Renner C, Bode W, Moroder L. Macrocyclic statine-based inhibitors of BACE-1. ChemBio Chem 2007; 8: 2078-2091.
21. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis J-C, Collins F, Treanor J, Rogers G, Citron M. β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999; 286: 735-741.
22. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, Brashler JR, Stratman NC, Mathews WR, Buhl AE, Carter DB, Tomasselli AG, Parodi LA, Heinrikson RL, Gurney ME. Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity. Nature 1999; 402: 533-537.
23. Koike H, Seki H, Kouchi Z, Ito M, Kinouchi T, Tomioka S, Sorimachi H, Saido TC, Maruyama K, Suzuki K, Ishiura S. Thimet oligopeptidase cleaves the full-length Alzheimer amyloid precursor protein at a β-secretase cleavage site in COS cells. J. Biochem. 1999; 126: 235-242.
24. Suzuki M, Noyori R, Langstrom B, Watanabe Y. Molecular design of prostaglandin probes in brain research: high, specific binding to a novel prostacyclin receptor in the central nervous system. Bull. Chem. Soc. Jpn. 2000; 73: 1053-1070.
25. Lee KS, Seon SH, Lee YH, Kim HD, Son MH, Chung BY, Lee JY, Jin C, Lee YS. Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors. Bioorg. Med. Chem. Lett. 2005; 15: 2857-2860. (Pubitemid 40732234)
26. Nam DH, Lee KS, Kim SH, Kim SM, Jung SY, Chung SH, Kim HJ, Kim ND, Jin C, Lee YS. Design and synthesis of 4-quinolinone 2-carboxamides as calpain inhibitors. Bioorg. Med. Chem. Lett. 2008; 18: 205-209.
27. Hong L, Koelsch G, Lin X, Wu S, Terzyan S, Ghosh AK, Zhang XC, Tang J. Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor. Science 2000; 290: 150-153.